Cargando…
Prognostic and Predictive Molecular Biomarkers for Colorectal Cancer: Updates and Challenges
Colorectal cancer (CRC) is a leading cause of death among cancer patients. This heterogeneous disease is characterized by alterations in multiple molecular pathways throughout its development. Mutations in RAS, along with the mismatch repair gene deficiency, are currently routinely tested in clinics...
Autores principales: | Koncina, Eric, Haan, Serge, Rauh, Stefan, Letellier, Elisabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072488/ https://www.ncbi.nlm.nih.gov/pubmed/32019056 http://dx.doi.org/10.3390/cancers12020319 |
Ejemplares similares
-
Tumor-Initiating Cells: a criTICal review of isolation approaches and new challenges in targeting strategies
por: Qureshi-Baig, Komal, et al.
Publicado: (2017) -
Loss of Myosin Vb in colorectal cancer is a strong prognostic factor for disease recurrence
por: Letellier, Elisabeth, et al.
Publicado: (2017) -
In search of definitions: Cancer‐associated fibroblasts and their markers
por: Nurmik, Martin, et al.
Publicado: (2019) -
Hypoxia-induced autophagy drives colorectal cancer initiation and progression by activating the PRKC/PKC-EZR (ezrin) pathway
por: Qureshi-Baig, Komal, et al.
Publicado: (2019) -
Hypoxia- and MicroRNA-Induced Metabolic Reprogramming of Tumor-Initiating Cells
por: Ullmann, Pit, et al.
Publicado: (2019)